Press coverage about Dolby Laboratories (NYSE:DLB) has trended somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dolby Laboratories earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned headlines about the electronics maker an impact score of 45.9692025493891 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
DLB stock traded down $1.59 during midday trading on Friday, hitting $63.01. 345,777 shares of the stock traded hands, compared to its average volume of 404,539. The firm has a market cap of $6,687.65, a PE ratio of 28.64, a P/E/G ratio of 5.43 and a beta of 0.74. Dolby Laboratories has a 1-year low of $48.00 and a 1-year high of $74.29.
Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Wednesday, January 24th. The electronics maker reported $0.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.44 by $0.35. The company had revenue of $287.80 million for the quarter, compared to analyst estimates of $265.75 million. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. The firm’s revenue was up 8.1% on a year-over-year basis. During the same quarter last year, the business earned $0.66 earnings per share. research analysts predict that Dolby Laboratories will post 0.99 EPS for the current year.
In related news, Director Peter C. Gotcher sold 5,233 shares of the firm’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $62.12, for a total transaction of $325,073.96. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Kevin J. Yeaman sold 68,548 shares of the firm’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $59.66, for a total transaction of $4,089,573.68. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 498,820 shares of company stock worth $31,288,698. 43.80% of the stock is owned by company insiders.
About Dolby Laboratories
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.